NME/NM23 Nucleoside Diphosphate Kinase 4 (NME4) (Middle Region) Peptide
NME4
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all NME4 products
- NME4 (NME/NM23 Nucleoside Diphosphate Kinase 4 (NME4))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-NME4 antibody (Catalog #: ARP56611_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NME4 (NME/NM23 Nucleoside Diphosphate Kinase 4 (NME4))
- Synonyms
- NDPK-D Peptide, NM23H4 Peptide, nm23-H4 Peptide, 2610027N22Rik Peptide, 2810024O08Rik Peptide, 5730493H09Rik Peptide, NM23-M4 Peptide, Nm23M4 Peptide, NME/NM23 nucleoside diphosphate kinase 4 Peptide, NME4 Peptide, Nme4 Peptide
- Background
-
The nucleoside diphosphate (NDP) kinases (EC 2.7.4.6) are ubiquitous enzymes that catalyze transfer of gamma-phosphates, via a phosphohistidine intermediate, between nucleoside and dioxynucleoside tri- and diphosphates. The enzymes are products of the nm2
Alias Symbols: NM23H4, nm23-H4, NDPK-D
Protein Interaction Partner: NME1,NME4,TRIP13,NME1,NME4,TRIP13
Protein Size: 187 - Molecular Weight
- 21 kDa
- Gene ID
- 4833
- NCBI Accession
- NM_005009, NP_005000
- UniProt
- O00746
-
You are here:
